An international panel proposed updated criteria for disease diagnosis, along with a more age-appropriate disease name and definition, for pediatric patients with NAFLD.
For patients with alcohol-related liver disease who require transplantation, there is mixed evidence supporting the requirement that patients abstain from alcohol consumption for 6 months prior to transplantation.
Researchers sought to determine the safety and efficacy of treatment with long-acting cabotegravir plus rilpivirine in patients with HIV coinfected with asymptomatic hepatitis c virus.
Investigators assessed the association between meat intake and risk for nonalcoholic fatty liver disease in a study cohort with low overall consumption of red meat.
Investigators assessed the relationship between passive smoking in children and adults with adult risk for fatty liver.
Researchers conducted a modeling study to determine the projected long-term impact of the COVID-19 pandemic on outcomes associated with hepatitis C virus care.
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
Researchers conducted a study that compared rapid treatment with a 7-day course of sofosbuvir-velpatasvir with usual compare in patients with hepatitis C virus infection who use injectable drugs.
The approval was based on data from the phase 2b ICONIC study, along with 5 years of data from supportive studies.
Investigators evaluated the antitumor activity of infigratinib in patients with previously treated, locally advanced or metastatic cholangiocarcinoma and FGFR2 alterations.
Based on a mathematical model, investigators evaluated improvements to the care cascade for people with hepatitis C virus who inject drugs.
The American Gastroenterological Association offered strategies for clinical practice, future research, and policy agenda for the treatment of patients with NAFLD and NASH.
The researchers note that among Hispanic individuals in the continental United States and Hawaii in 2021, an estimated 176,600 new cancer cases and 46,500 cancer deaths will occur.
The investigators sought to determine the down-staging success rate and intention-to-treat outcomes according to uniform criteria in patients with hepatocellular carcinoma.
Researchers investigated the impact of COVID-19 on patients waiting for liver transplants, as well as on the clinical course following transplantation.
Researchers aimed to assess the safety and efficacy of fatty acid synthase inhibitor TVB-2640 on liver fat and biomarkers for liver and metabolic health in patients with NASH.
There has been a widening rural-urban disparity in changes in new cases of hepatocellular carcinoma (HCC) during the past two decades.
Investigators aimed to determine the association between maternal gestational elevated serum total bile acid concentrations and the risk for intrauterine growth restrictions.
CAM2029 is an investigational ready-to-use, long-acting octreotide subcutaneous injection depot.
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.